Cargando…
Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer
BACKGROUND: Tumor necrosis factor (TNF) has been investigated to be correlated with the occurrence and progression of lung cancer. This investigation was to assess the efficacy and safety of recombinant mutant human tumor necrosis factor (rmhTNF) for controlling malignant pleural effusion (MPE) thro...
Autores principales: | Fu, Tian, Lin, Yong, Zeng, Qingdi, Yao, Wei, Han, Liping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301477/ https://www.ncbi.nlm.nih.gov/pubmed/32552897 http://dx.doi.org/10.1186/s12890-020-01210-x |
Ejemplares similares
-
Thoracic perfusion of matrine as an adjuvant treatment improves the control of the malignant pleural effusions
por: Biaoxue, Rong, et al.
Publicado: (2015) -
Parallel readout of the CERN RMH system using transputers
por: Pagès, J L, et al.
Publicado: (1992) -
Thoracic injection of low-dose interleukin-2 as an adjuvant therapy improves the control of the malignant pleural effusions: a systematic review and meta-analysis base on Chinese patients
por: Han, Liping, et al.
Publicado: (2018) -
Thoracic herniation secondary to pleural effusion
por: Romero, Carlos, et al.
Publicado: (2018) -
The Meta-Analysis of Bevacizumab Combined with Platinum-Based Treatment of Malignant Pleural Effusions by Thoracic Perfusion
por: Shen, Bairu, et al.
Publicado: (2022)